Joint Meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting

Summary

The FDA will host a joint meeting of the Arthritis Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee to discuss the safety and efficacy of new treatments for arthritis. The meeting is scheduled to take place on March 15, 2023, at the FDA White Oak Campus in Silver Spring, Maryland.